|
Volumn 12, Issue 3, 2013, Pages 269-270
|
BCL-2 inhibition: Stemming the tide of myeloid malignancies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABT 199;
ANTILEUKEMIC AGENT;
GOSSYPOL;
NAVITOCLAX;
PROTEIN BCL 2;
PROTEIN BCL XL;
REACTIVE OXYGEN METABOLITE;
UNCLASSIFIED DRUG;
ACUTE GRANULOCYTIC LEUKEMIA;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER RESISTANCE;
CANCER STEM CELL;
CHRONIC MYELOID LEUKEMIA;
DRUG MECHANISM;
DRUG TARGETING;
HUMAN;
LEUKEMIA CELL;
LEUKEMIA STEM CELL;
MYELOID LEUKEMIA;
NONHUMAN;
OXIDATIVE STRESS;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
|
EID: 84875165288
PISSN: 19345909
EISSN: 18759777
Source Type: Journal
DOI: 10.1016/j.stem.2013.02.006 Document Type: Short Survey |
Times cited : (7)
|
References (10)
|